Melphalan

tumor necrosis factor ; Mus musculus







11 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 28969419 Targeted Cancer Therapy Using Fusion Protein of TNFα and Tumor-Associated Fibronectin-Specific Aptide. 2017 Nov 6 1
2 17330231 Direct evidence for rapid and selective induction of tumor neovascular permeability by tumor necrosis factor and a novel derivative, colloidal gold bound tumor necrosis factor. 2007 Jun 1 1
3 18022863 Therapy-induced antitumor vaccination by targeting tumor necrosis factor alpha to tumor vessels in combination with melphalan. 2007 Dec 1
4 16397040 Synergistic antitumor activity of cisplatin, paclitaxel, and gemcitabine with tumor vasculature-targeted tumor necrosis factor-alpha. 2006 Jan 1 3
5 16148157 Kupffer cell-expressed membrane-bound TNF mediates melphalan hepatotoxicity via activation of both TNF receptors. 2005 Sep 15 5
6 11673494 Melphalan-induced expression of IFN-beta in MOPC-315 tumor-bearing mice and its importance for the up-regulation of TNF-alpha expression. 2001 Nov 1 2
7 10452985 Norepinephrine-mediated inhibition of antitumor cytotoxic T lymphocyte generation involves a beta-adrenergic receptor mechanism and decreased TNF-alpha gene expression. 1999 Sep 1 1
8 9225006 Potentiation of antitumor CTL response by GM-CSF involves a B7-dependent mechanism. 1997 Jun 15 1
9 7706732 Importance of TNF production for the curative effectiveness of low dose melphalan therapy for mice bearing a large MOPC-315 tumor. 1995 Apr 15 1
10 7882302 Cytotoxic interactions of tumor necrosis factor, melphalan and 41.8 degrees C hyperthermia. 1995 Feb 10 2
11 8635194 Low-dose-melphalan-induced up-regulation of type-1 cytokine expression in the s.c. tumor nodule of MOPC-315 tumor bearers and the role of interferon gamma in the therapeutic outcome. 1995 Dec 5